-
-
-
-
-
-
-
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Lowered to $18 at Truist Securities
-
-
-
-
-
-
-
HIMS to acquire Australia's Eucalyptus for up to $1.15 billion
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Lowered to $29 at BofA Securities, 'Sales and EBITDA margin expectations are too high'
-
-
-
-
-
-
-
Hims & Hers Health (HIMS) Tops Q2 EPS by 2c, Revenue Misses, Offers Guidance
-
-
-
-
-
-
-
Leerink on Hims and Hers (HIMS) Canadian Expansion: 'We view this as a potential incremental revenue driver into 2026, though execution and uptake will be key to watch'
-
-
-
-
-
-
-
Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 3c; Issues Mixed Outlook
-
1,205,121 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

